CCTG

PA.6

NCT01526135

PA.6

Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma

Status:

Closed to Accrual

26459-200.png

III

Phase

Line of Therapy.png

Adjuvant

Line of Therapy

Disease Stage.png

Advanced / Metastatic

Disease Stage

Target.png

Biomarker(s)

N/A

Investigational

Product

mFOLFIRINOX

Treatment Arms

o Active Comparator: Arm A GEMCITABINE

o Experimental: Arm B mFOLFIRINOX